Literature DB >> 7572425

A highly sensitive and rapid procedure for direct PCR detection of Leishmania infantum within human peripheral blood mononuclear cells.

S Ravel1, G Cuny, J Reynes, F Veas.   

Abstract

We have developed a highly sensitive, simple and rapid procedure to detect Leishmania infantum within human macrophages. It only requires ficoll preparation of peripheral blood mononuclear cells from the patient, and their direct use for Leishmania kDNA amplification by polymerase chain reaction. Under these conditions, about one parasite can be detected in a one million human cell environment. Results, including those of a hybridization step to confirm the diagnosis specificity, are obtained with 24 h, a very short period as compared to current diagnostic methods. This procedure is of particular interest for early detection and early drug treatment of leishmaniasis, especially in the case of HIV coinfection. Furthermore, the method could be useful for monitoring the efficiency of new leishmaniasis treatments in infected patients.

Entities:  

Mesh:

Year:  1995        PMID: 7572425     DOI: 10.1016/0001-706x(95)00079-t

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  15 in total

1.  Quantitative real-time PCR is not more sensitive than "conventional" PCR.

Authors:  Patrick Bastien; Gary W Procop; Udo Reischl
Journal:  J Clin Microbiol       Date:  2008-04-09       Impact factor: 5.948

2.  Detection of Leishmania (Leishmania) infantum RNA in fleas and ticks collected from naturally infected dogs.

Authors:  Fabio A Colombo; Rosa M F N Odorizzi; Marcia D Laurenti; Eunice A B Galati; Flavio Canavez; Vera L Pereira-Chioccola
Journal:  Parasitol Res       Date:  2011-01-11       Impact factor: 2.289

Review 3.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  Genetic heterogeneity in clinical isolates of Leishmania donovani from India.

Authors:  Pankaj Srivastava; Toolika Singh; Shyam Sundar
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

5.  New primers for the detection Leishmania species by multiplex polymerase chain reaction.

Authors:  Carolina Cella Conter; Maria Valdrinez Campana Lonardoni; Sandra Mara Alessi Aristides; Rosilene Fressatti Cardoso; Thaís Gomes Verzignassi Silveira
Journal:  Parasitol Res       Date:  2017-12-26       Impact factor: 2.289

6.  Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France.

Authors:  Y le Fichoux; J F Quaranta; J P Aufeuvre; A Lelievre; P Marty; I Suffia; D Rousseau; J Kubar
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

7.  Low sensitivity of peripheral blood smear for diagnosis of subclinical visceral leishmaniasis in human immunodeficiency virus type 1-infected patients.

Authors:  J Delgado; J A Pineda; J Macías; C Regordán; J A Gallardo; M Leal; A Sanchez-Quijano; E Lissen
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

8.  [Cutaneous leishmaniasis--an import from Belize].

Authors:  Jakob Schnedl; Herbert Auer; Marcellus Fischer; Herbert Tomaso; Tom Pustelnik; Gerhard Mooseder
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

9.  Leishmania infantum INFECTION IN DOGS FROM THE SOUTHERN REGION OF MINAS GERAIS STATE, BRAZIL.

Authors:  Juliana Barbosa Nunes; Márcia Dalastra Laurenti; Herminia Yohko Kanamura; Alessandro Antônio Costa Pereira; Fabio Antonio Colombo; Marcos José Marques
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-11-03       Impact factor: 1.846

10.  Single-step multiplex PCR assay for characterization of New World Leishmania complexes.

Authors:  E Harris; G Kropp; A Belli; B Rodriguez; N Agabian
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.